Sara Alharbi

3PUBLICATIONS
5CO-AUTHORS
Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 07, 2026
MEK Inhibition Reduces Vascular Malformations and Gene Dysregulation in NRASQ61R Human Endothelial Cells.

Sara Alharbi, Andrew Wagner, Svatava Merkle

|Feb 21, 2025
RAS Pathway Mutations and Therapeutics in Vascular Anomalies.

Sara Alharbi, Svatava Merkle, Adrienne M Hammill

|Dec 26, 2024
Lyve1-Driven NrasQ61R Causes Edema, Enlarged Lymphatic Vessels, and Hepatic Vascular Defects in Embryonic Mice.

C Griffin McDaniel, Dermot Fox, Patricia Pastura

Pageof 1